Bottle of Lies by Katherine Eban audiobook

Bottle of Lies: The Inside Story of the Generic Drug Boom

By Katherine Eban
Read by Katherine Eban

HarperAudio, HarperCollins 9780062338785
14.42 Hours Unabridged
Format: Digital Download (In Stock)
  • Regular Price: $29.99

    Special Price $12.00

    or 1 Credit

    ISBN: 9780062917645

  • Regular Price: $39.99

    Special Price $20.00

    ISBN: 9781982656416

  • Regular Price: $39.99

    Special Price $20.00

    ISBN: 9781982656423

From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization—The Jungle for pharmaceuticals The widespread use of generic drugs has been hailed as one of the most important public health developments of the twentieth century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our pharmacists, our doctors, and our regulators that the generic and brand-name drugs are identical, generics just cheaper. But is this really true? Katherine Eban’s Bottle of Lies exposes the widespread deceit behind generic drug manufacturing—creating terrifying risks for global health. Drawing on exclusive accounts from whistleblowers, inspectors, and regulators, as well as thousands of pages of confidential internal FDA documents, Eban reveals an industry where fraud is rampant, companies falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume adulterated medicine with unpredictable and even life-threatening effects.  The story of generic drugs is truly global: it connects middle America to sub-Saharan Africa, China, India, and Brazil, and encompasses every market banking on the promise of a low-cost cure. Given that tens of millions of patients take drugs of dubious quality approved with fake data, the generics industry is the ultimate litmus test of globalization: what is the risk of moving drug manufacturing offshore, and is it worth the savings?         An investigation with international sweep, exotic settings, molecular mayhem, and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.  

Learn More
Membership Details
  • Only $12.99/month gets you 1 Credit/month
  • Cancel anytime
  • Hate a book? Then we do too, and we'll exchange it.
See how it works in 15 seconds

Summary

Summary

A New York Times Book Review Editor’s Choice

From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization—The Jungle for pharmaceuticals

The widespread use of generic drugs has been hailed as one of the most important public health developments of the twentieth century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our pharmacists, our doctors, and our regulators that the generic and brand-name drugs are identical, generics just cheaper. But is this really true?

Katherine Eban’s Bottle of Lies exposes the widespread deceit behind generic drug manufacturing—creating terrifying risks for global health. Drawing on exclusive accounts from whistleblowers, inspectors, and regulators, as well as thousands of pages of confidential internal FDA documents, Eban reveals an industry where fraud is rampant, companies falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume adulterated medicine with unpredictable and even life-threatening effects. 

The story of generic drugs is truly global: it connects middle America to sub-Saharan Africa, China, India, and Brazil, and encompasses every market banking on the promise of a low-cost cure. Given that tens of millions of patients take drugs of dubious quality approved with fake data, the generics industry is the ultimate litmus test of globalization: what is the risk of moving drug manufacturing offshore, and is it worth the savings?     

  

An investigation with international sweep, exotic settings, molecular mayhem, and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.  

Editorial Reviews

Editorial Reviews

“A shocking exposé of corporate greed, arrogance, and eagerness to exploit the weak for profit….Bottle of Lies is an important work of investigative journalism. Anyone who takes prescription drugs should read it.” Eric Schlosser, New York Times bestselling author
“This book will save lives…What Rachel Carson did for our understanding of the perils facing the environment Katherine Eban has now done for our understanding of the threats to our health from the drugs we take every day. Bottle of Lies is Katherine Eban’s masterwork of global investigative reporting.” James Risen, Pulitzer Prize winner and New York Times bestselling author
“Riveting and increasingly foreboding…An invaluable exposé, a reportorial tour de force, and a well-turned epic.” New York Times
“Propulsive…astounding…disturbing.” NPR
“An urgent, alarming work of health reporting that will make you question every drug in your medicine cabinet.” Kirkus Reviews (starred review)

Reviews

Reviews

Author

Author Bio: Katherine Eban

Author Bio: Katherine Eban

Titles by Author

Details

Details

Available Formats : Digital Download, CD, MP3 CD
Category: Nonfiction/Business & Economics
Runtime: 14.42
Audience: Adult
Language: English